(Q24299189)
Statements
Crystallographic analysis reveals that anticancer clinical candidate L-778,123 inhibits protein farnesyltransferase and geranylgeranyltransferase-I by different binding modes (English)
0 references
20 July 2004
0 references
43
0 references
28
0 references
9000-8
0 references